United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 21, 2026 · Filed Aug 24, 2026

On Aug 21, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$518.39 for US$4.92M under a trading plan, leaving 324,443 shares. Filed Aug 24, 2026 (Form 4).

Sold
9,500 shares
Price
US$518.39 average (US$512.71 to US$527.71)
Value
US$4.92M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 21, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 21, 2026Common StockSale1,189US$512.71332,754Indirect
Aug 21, 2026Common StockSale271US$513.85332,483Indirect
Aug 21, 2026Common StockSale624US$515.26331,859Indirect
Aug 21, 2026Common StockSale1,689US$516.15330,170Indirect
Aug 21, 2026Common StockSale773US$517.07329,397Indirect
Aug 21, 2026Common StockSale1,077US$518.14328,320Indirect
Aug 21, 2026Common StockSale837US$519.09327,483Indirect
Aug 21, 2026Common StockSale440US$520.03327,043Indirect
Aug 21, 2026Common StockSale371US$521.28326,672Indirect
Aug 21, 2026Common StockSale669US$522.29326,003Indirect
Aug 21, 2026Common StockSale455US$523.62325,548Indirect
Aug 21, 2026Common StockSale625US$524.35324,923Indirect
Aug 21, 2026Common StockSale235US$525.42324,688Indirect
Aug 21, 2026Common StockSale45US$526.47324,643Indirect
Aug 21, 2026Common StockSale200US$527.71324,443Indirect

Source

View original at SEC

Related